Stilla Technologies is a Paris-based Biotechnology company focusing on developing next-generation genetic tests in Life Science research, from diagnostics and therapeutics to ‘omics’. We use a ground-breaking integrated digital PCR (dPCR) solution, the Naica System™. Based on a cutting-edge microfluidic technique, superior precision, and sensitivity for target detection, the Naica system offers unrivaled ease-of-use and a fast turnaround time (2h30). At Stilla, we strive to continuously develop assays for a wide range of applications in Life Science research, with the goal of making dPCR a lab commodity.